MX2013011623A - Regimenes de tratamiento. - Google Patents

Regimenes de tratamiento.

Info

Publication number
MX2013011623A
MX2013011623A MX2013011623A MX2013011623A MX2013011623A MX 2013011623 A MX2013011623 A MX 2013011623A MX 2013011623 A MX2013011623 A MX 2013011623A MX 2013011623 A MX2013011623 A MX 2013011623A MX 2013011623 A MX2013011623 A MX 2013011623A
Authority
MX
Mexico
Prior art keywords
treatment regimens
hsdd
compounds
subject
methods
Prior art date
Application number
MX2013011623A
Other languages
English (en)
Other versions
MX354989B (es
Inventor
Nicolas G Sitchon
Original Assignee
S1 Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S1 Biopharma Inc filed Critical S1 Biopharma Inc
Publication of MX2013011623A publication Critical patent/MX2013011623A/es
Publication of MX354989B publication Critical patent/MX354989B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invención se refiere además a los compuestos, composiciones farmacéuticas y métodos para tratar el trastorno hipoactivo del deseo sexual (HSDD) en un sujeto.
MX2013011623A 2011-04-04 2012-04-03 Regimenes de tratamiento. MX354989B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161471505P 2011-04-04 2011-04-04
PCT/US2012/031991 WO2012138653A2 (en) 2011-04-04 2012-04-03 Treatment regimens

Publications (2)

Publication Number Publication Date
MX2013011623A true MX2013011623A (es) 2014-03-27
MX354989B MX354989B (es) 2018-03-28

Family

ID=46969773

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013011623A MX354989B (es) 2011-04-04 2012-04-03 Regimenes de tratamiento.

Country Status (25)

Country Link
US (1) US20140038985A1 (es)
EP (2) EP2694065B1 (es)
JP (2) JP6279465B2 (es)
KR (3) KR102141519B1 (es)
CN (1) CN103635190B (es)
AU (3) AU2012240388A1 (es)
BR (1) BR112013025794A2 (es)
CA (1) CA2832306A1 (es)
CY (1) CY1120545T1 (es)
DK (1) DK2694065T3 (es)
EA (1) EA201391459A1 (es)
ES (1) ES2662570T3 (es)
HR (1) HRP20180417T1 (es)
HU (1) HUE036977T2 (es)
IL (1) IL228729A0 (es)
LT (1) LT2694065T (es)
MX (1) MX354989B (es)
NO (1) NO2746714T3 (es)
PL (1) PL2694065T3 (es)
PT (1) PT2694065T (es)
RS (1) RS57133B1 (es)
SG (2) SG10201609297VA (es)
SI (1) SI2694065T1 (es)
WO (1) WO2012138653A2 (es)
ZA (1) ZA201307760B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2694065T3 (pl) * 2011-04-04 2018-06-29 S1 Biopharma, Inc. Kompozycja do leczenia zaburzenia hipoaktywnego pożądania seksualnego
WO2014025814A1 (en) 2012-08-06 2014-02-13 S1 Pharmaceuticals, Inc. Treatment regimens
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005102342A1 (en) * 2004-04-22 2005-11-03 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for the treatment of sexual disorders ii
US20060004076A1 (en) * 2004-06-30 2006-01-05 Inflabloc Pharmaceuticals, Inc. Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation
US7769770B2 (en) * 2004-07-14 2010-08-03 Microsoft Corporation Secondary index and indexed view maintenance for updates to complex types
JP4201747B2 (ja) * 2004-07-29 2008-12-24 三洋電機株式会社 自走式掃除機
JP2008538741A (ja) * 2005-03-04 2008-11-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 鬱病の治療用及び／又は予防用の医薬組成物
WO2008075162A2 (en) * 2006-12-15 2008-06-26 Pfizer Limited Selective mu opioid receptor antagonists for the treatment of female sexual dysfunction
PL2694065T3 (pl) * 2011-04-04 2018-06-29 S1 Biopharma, Inc. Kompozycja do leczenia zaburzenia hipoaktywnego pożądania seksualnego

Also Published As

Publication number Publication date
IL228729A0 (en) 2013-12-31
SI2694065T1 (en) 2018-06-29
JP6563998B2 (ja) 2019-08-21
KR20140031890A (ko) 2014-03-13
EA201391459A1 (ru) 2014-03-31
RS57133B1 (sr) 2018-07-31
DK2694065T3 (en) 2018-03-19
EP2694065B1 (en) 2017-12-13
BR112013025794A2 (pt) 2018-05-29
EP3332780A1 (en) 2018-06-13
KR102033699B1 (ko) 2019-10-17
EP2694065A2 (en) 2014-02-12
JP2018030870A (ja) 2018-03-01
CA2832306A1 (en) 2012-10-11
JP2014510138A (ja) 2014-04-24
KR101893551B1 (ko) 2018-08-30
AU2012240388A8 (en) 2013-11-14
AU2017203815A1 (en) 2017-06-22
HUE036977T2 (hu) 2018-08-28
CN103635190A (zh) 2014-03-12
KR102141519B1 (ko) 2020-08-06
SG10201609297VA (en) 2016-12-29
MX354989B (es) 2018-03-28
PL2694065T3 (pl) 2018-06-29
AU2018264030A1 (en) 2018-12-06
ES2662570T3 (es) 2018-04-09
NO2746714T3 (es) 2018-02-03
CY1120545T1 (el) 2019-07-10
WO2012138653A3 (en) 2012-12-06
LT2694065T (lt) 2018-04-10
SG194071A1 (en) 2013-11-29
PT2694065T (pt) 2018-03-20
EP2694065A4 (en) 2014-08-27
KR20180099910A (ko) 2018-09-05
JP6279465B2 (ja) 2018-02-14
HRP20180417T1 (hr) 2018-06-01
US20140038985A1 (en) 2014-02-06
CN103635190B (zh) 2016-09-07
WO2012138653A2 (en) 2012-10-11
KR20190120400A (ko) 2019-10-23
ZA201307760B (en) 2015-01-28
AU2012240388A1 (en) 2013-10-24

Similar Documents

Publication Publication Date Title
PH12015502075B1 (en) Treatment of cataplexy
MX2019009437A (es) Tratamiento de mielosupresion.
PL2672966T3 (pl) Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
SI2729151T1 (sl) Farmacevtski sestavek, postopki za zdravljenje in njihove uporabe
MX2020010991A (es) Composicion para la estimulacion ovarica controlada.
MX349224B (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa.
MX2014004074A (es) Metodo de tratamiento de condiciones del higado utilizando antagonistas de notch2.
MX2017000306A (es) Metodos para tratar hipotension.
MX2020009966A (es) Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina.
NZ707636A (en) Ingenol-derived compounds that can be used for treating cancer
HRP20180417T1 (hr) Pripravak za liječenje poremećaja hipoaktivne seksualne želje
EA201491581A1 (ru) Везикулярные композиции
EA201590615A1 (ru) Стимулирующие лактацию композиции на основе фосфатидилсерина
MX2016002307A (es) Tratamiento para el cancer.
MX2015012505A (es) Métodos mejorados para tratamiento de grano con ozono.
MX2015001695A (es) Regimenes de tratamiento.
MY184721A (en) Use of odiparcil in the treatment of a mucopolysaccharidosis
MX350868B (es) Medicamentos y metodos para tratar cancer.
EP2741608A4 (en) IMPROVED PLANT TREATMENT AGENT
PH12014000104A1 (en) Therapeutic methods and compositions for treating diabetes
UA103980C2 (ru) Способ консервативного лечения апоплексии яичника с минимальным гемоперитонеумом
GB201116328D0 (en) Treatment for tumours

Legal Events

Date Code Title Description
FG Grant or registration